Dasatinib adverse reactions

Dasatinib (Dasatinib) is a cancer drug that slows the growth and spread of cancer cells in the body. As a drug for the treatment of chronic myelogenous leukemia and certain acute lymphoblastic leukemias, dasatinib has significant efficacy, but some adverse reactions may occur during use.

Some patients may experience grade 3-4 bone marrow suppression while taking dasatinibGrade 3-4 bone marrow suppression, which is usually manifested by a decrease in platelets, neutrophils, and hemoglobin. In addition, a small number of patients may develop febrile neutropenia and systemic cytopenias. After taking dasatinib, some patients may experience gastrointestinal discomfort symptoms such as vomiting, nausea, abdominal pain, and diarrhea. Patients who take medicine for a long time may also develop colitis, gastrointestinal bleeding, gastritis and other diseases. Some patients may develop cardiovascular problems such as congestive heart failure, cardiac dysfunction, pericardial effusion, and irregular heartbeats after taking dasatinib. Rash is one of the common skin reactions of dasatinib, and some patients may also experience discomfort such as skin flushing, hair loss, and dermatitis. In rare cases, patients may develop severe kidney damage such as kidney failure.

In addition to the above adverse reactions, dasatinib may also cause metabolic abnormalities, respiratory problems, and systemic reactions, such as fatigue and weakness.

It should be emphasized that although dasatinib may cause some adverse reactions, it still has significant efficacy in the treatment of leukemia. Patients should follow the doctor's instructions when using it and pay close attention to their physical condition. If you feel any discomfort, seek medical attention immediately.